The price of this share is at 9,58$, Amicus Therapeutics Inc, with address at 3675 MARKET STREET, PHILADELPHIA, Pennsylvania, 19104, United States, is a publicly traded company and its visible heads at the moment are Bradley Lewis Campbell (President, Chief Operating Officer & Director), Daphne E. Quimi (Chief Financial Officer), Hung Do (Chief Science Officer), John Francis Crowley (Chairman & Chief Executive Officer). Focused on Biotechnology: Pharmaceutical Preparations was created long ago in United States.
Today this action begins with yesterday's closing price, desconocido$.
The current range on the same day is from 9,34$ - 9,59$, with a percentage difference of 9,47$ quite wide that helps to be able to do day trading.
Their latest annual data shows an income of desconocido.
The last registered opening is of desconocido.
To detect if it is a good time to enter or exit a stock, many traders use the lowest and highest values of the last 52 weeks. In this action, prices have moved between 0,00$ and 0,00$.
EPS is the net profit that the company has obtained, after paying taxes, divided by the number of total shares it has in circulation. This value is higher the better the company has done, although with some nuances since it can increase if the number of shares for sale decreases, or it can decrease if things that have happened in just a few months are charged annually. For this action the BPA is [BPA].